# Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

> **NCT03906617** · PHASE4 · RECRUITING · sponsor: **The Cooper Health System** · enrollment: 34 (estimated)

## Conditions studied

- Robotic Lung Surgery

## Interventions

- **DRUG:** Intercostal nerve block and wound infiltration with liposomal bupivacaine
- **DRUG:** Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone

## Key facts

- **NCT ID:** NCT03906617
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-10
- **Primary completion:** 2022-04-10
- **Final completion:** 2022-06-10
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03906617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03906617, "Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03906617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*